AI assistant
PRECISION BIOSCIENCES INC — Director's Dealing 2019
Mar 27, 2019
34491_dirs_2019-03-27_6b1a605c-7a86-46ed-bee2-951074f7ddb1.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: PRECISION BIOSCIENCES INC (DTIL)
CIK: 0001357874
Period of Report: 2019-03-27
Reporting Person: KANE MATTHEW R. (Director, President and CEO, 10% Owner)
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 1802427 | Direct |
| Common Stock | 8067 | Indirect |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Employee Stock Option (Right to Buy) | $0.04 | 2021-05-17 | Common Stock (322711) | Direct | |
| Employee Stock Option (Right to Buy) | $1.18 | 2027-03-23 | Common Stock (23422) | Direct | |
| Employee Stock Option (Right to Buy) | $11.98 | 2028-09-27 | Common Stock (140535) | Direct | |
| Employee Stock Option (Right to Buy) | $1.18 | 2027-03-23 | Common Stock (16395) | Indirect | |
| Employee Stock Option (Right to Buy) | $8.99 | 2028-04-05 | Common Stock (21080) | Indirect | |
| Employee Stock Option (Right to Buy) | $11.98 | 2028-09-27 | Common Stock (7026) | Indirect |
Footnotes
F1: Securities are held by Chelsea Lynam, the spouse of the reporting person. The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein.
F2: The option is fully vested.
F3: The option vests as to 25% of the underlying shares on March 24, 2018 and vests in equal installments at the end of each successive three-month period over the following 36 months.
F4: The option vests as to 25% of the underlying shares on September 28, 2019 and vests in equal installments at the end of each successive three-month period over the following 36 months.
F5: The option vests as to 25% of the underlying shares on March 24, 2018 and vests in equal installments at the end of each successive three-month period over the following 36 months.
F6: The option vests as to 25% of the underlying shares on April 6, 2019 and vests in equal installments at the end of each successive three-month period over the following 36 months.
F7: The option vests as to 25% of the underlying shares on September 28, 2019 and vests in equal installments at the end of each successive three-month period over the following 36 months.